Results of a randomized phase II study of two schedules of bryostatin-I in patients with malignant melanoma: experience with the multivariate stopping rule
Year: 1999
Type: article
Source: European Journal of Cancer
Authors: K. Belanger, R. Tozer, S. Burdette-Radoux, M. Davis, R. Lohmann, B. Zee, N. Wainman, L. Seymour
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2019678015
